Documenting patients' and providers' preferences when proposing a randomized controlled trial: a qualitative exploration.

Breast cancer Cancer care coordination Cancer survivors Oncology nurse Telephone survivorship clinic Transition of care

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
06 03 2022
Historique:
received: 03 03 2021
accepted: 14 02 2022
entrez: 7 3 2022
pubmed: 8 3 2022
medline: 22 3 2022
Statut: epublish

Résumé

With advances in cancer diagnosis and treatment, women with early-stage breast cancer (ESBC) are living longer, increasing the number of patients receiving post-treatment follow-up care. Best-practice survivorship models recommend transitioning ESBC patients from oncology-provider (OP) care to community-based care. While developing materials for a future randomized controlled trial (RCT) to test the feasibility of a nurse-led Telephone Survivorship Clinic (TSC) for a smooth transition of ESBC survivors to follow-up care, we explored patients' and OPs' reactions to several of our proposed methods. We used a qualitative study design with thematic analysis and a two-pronged approach. We interviewed OPs, seeking feedback on ways to recruit their ESBC patients for the trial, and ESBC patients, seeking input on a questionnaire package assessing outcomes and processes in the trial. OPs identified facilitators and barriers and offered suggestions for study design and recruitment process improvement. Facilitators included the novelty and utility of the study and simplicity of methods; barriers included lack of coordination between treating and discharging clinicians, time constraints, language barriers, motivation, and using a paper-based referral letter. OPs suggested using a combination of electronic and paper referral letters and supporting clinicians to help with recruitment. Patient advisors reported satisfaction with the content and length of the assessment package. However, they questioned the relevance of some questions (childhood trauma) while adding questions about trust in physicians and proximity to primary-care providers. OPs and patient advisors rated our methods for the proposed trial highly for their simplicity and relevance then suggested changes. These findings document processes that could be effective for cancer-patient recruitment in survivorship clinical trials.

Sections du résumé

BACKGROUND
With advances in cancer diagnosis and treatment, women with early-stage breast cancer (ESBC) are living longer, increasing the number of patients receiving post-treatment follow-up care. Best-practice survivorship models recommend transitioning ESBC patients from oncology-provider (OP) care to community-based care. While developing materials for a future randomized controlled trial (RCT) to test the feasibility of a nurse-led Telephone Survivorship Clinic (TSC) for a smooth transition of ESBC survivors to follow-up care, we explored patients' and OPs' reactions to several of our proposed methods.
METHODS
We used a qualitative study design with thematic analysis and a two-pronged approach. We interviewed OPs, seeking feedback on ways to recruit their ESBC patients for the trial, and ESBC patients, seeking input on a questionnaire package assessing outcomes and processes in the trial.
RESULTS
OPs identified facilitators and barriers and offered suggestions for study design and recruitment process improvement. Facilitators included the novelty and utility of the study and simplicity of methods; barriers included lack of coordination between treating and discharging clinicians, time constraints, language barriers, motivation, and using a paper-based referral letter. OPs suggested using a combination of electronic and paper referral letters and supporting clinicians to help with recruitment. Patient advisors reported satisfaction with the content and length of the assessment package. However, they questioned the relevance of some questions (childhood trauma) while adding questions about trust in physicians and proximity to primary-care providers.
CONCLUSIONS
OPs and patient advisors rated our methods for the proposed trial highly for their simplicity and relevance then suggested changes. These findings document processes that could be effective for cancer-patient recruitment in survivorship clinical trials.

Identifiants

pubmed: 35249528
doi: 10.1186/s12874-022-01549-1
pii: 10.1186/s12874-022-01549-1
pmc: PMC8898414
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

64

Informations de copyright

© 2022. The Author(s).

Références

Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Psychooncology. 2011 Mar;20(3):227-41
pubmed: 20878840
Breast Cancer Res Treat. 2011 Apr;126(2):529-37
pubmed: 20803066
J Clin Oncol. 2009 May 20;27(15):2489-95
pubmed: 19332716
J Cancer Surviv. 2012 Dec;6(4):359-71
pubmed: 22777364
J Cancer Surviv. 2013 Sep;7(3):343-54
pubmed: 23526165
J Oncol Pract. 2015 May;11(3):e296-303
pubmed: 25980018
J Cancer Surviv. 2007 Jun;1(2):167-75
pubmed: 18648958
J Oncol Pract. 2015 May;11(3):e288-95
pubmed: 25852142
Psychooncology. 2013 Aug;22(8):1866-71
pubmed: 23203833
J Clin Oncol. 2010 Jan 20;28(3):509-18
pubmed: 19949017
BMC Med Res Methodol. 2015 Aug 12;15:60
pubmed: 26264621
J Cancer Surviv. 2011 Dec;5(4):358-70
pubmed: 21968543
Cancer. 2016 Aug 1;122(15):2408-17
pubmed: 27198057
Can Fam Physician. 2016 Oct;62(10):805-811
pubmed: 27737976
Breast. 2017 Dec;36:1-13
pubmed: 28843976
Med Sci Sports Exerc. 1993 Jan;25(1):81-91
pubmed: 8423759
J Clin Oncol. 1997 Mar;15(3):974-86
pubmed: 9060536
J Natl Compr Canc Netw. 2015 Jun;13(6):762-71
pubmed: 26085392
Curr Oncol. 2011 Dec;18(6):e265-81
pubmed: 22184494
Cancer. 2015 Feb 1;121(3):476-84
pubmed: 25367403
Cancer Prev Res (Phila). 2012 Jan;5(1):98-108
pubmed: 21982875
J Clin Oncol. 2011 Dec 20;29(36):4755-62
pubmed: 22042959
J Cancer Surviv. 2012 Dec;6(4):468-75
pubmed: 23054849
J Clin Oncol. 2011 Dec 20;29(36):4740-2
pubmed: 22042961
Oncol Nurs Forum. 2014 Nov 1;41(6):615-25
pubmed: 25355017
Sleep. 2014 May 01;37(5):837-42
pubmed: 24790261
BMC Health Serv Res. 2010 May 20;10:132
pubmed: 20482884
Spec Care Dentist. 2009 Jul-Aug;29(4):147-8
pubmed: 19573040
J Cancer Surviv. 2013 Mar;7(1):124-30
pubmed: 23184488
Int J Qual Health Care. 2008 Oct;20(5):314-23
pubmed: 18635587
Curr Oncol. 2014 Feb;21(1):e18-28
pubmed: 24523618
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):857-64
pubmed: 24599578
Oncol Nurs Forum. 2002 Aug;29(7):1091-8
pubmed: 12183757
Lancet. 2011 Aug 27;378(9793):771-84
pubmed: 21802721

Auteurs

Devesh Oberoi (D)

Division of Psychosocial Oncology, Department of Oncology, Faculty of Medicine, Cumming School of Medicine, Department of Psychosocial Resources, Tom Baker Cancer Centre, Holy Cross Site, 2202 2nd St. SW, AB, T2S 3C1, Calgary, Canada. devesh.oberoi@albertahealthservices.ca.

Cynthia Kwok (C)

Medical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.

Yong Li (Y)

Medical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.

Cindy Railton (C)

Holy Cross Centre CancerControl Alberta, Alberta Health Services, AB, T2S 3C3, Calgary, Canada.

Susan Horsman (S)

Cross Cancer Institute, 1156 University Ave, AB, T6G 1Z2, Edmonton, Canada.

Kathleen Reynolds (K)

Long Term Survivors Clinic, Alberta Children's Hospital, 2888 Shaganappi Trail NW, AB, T3B 6AB, Calgary, Canada.

Anil A Joy (AA)

Cross Cancer Institute, 1156 University Ave, AB, T6G 1Z2, Edmonton, Canada.

Karen Marie King (KM)

Cross Cancer Institute, 1156 University Ave, AB, T6G 1Z2, Edmonton, Canada.

Sasha Michelle Lupichuk (SM)

Medical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.

Michael Speca (M)

Medical Oncology, Tom Baker Cancer Centre, 1331 29 St. NW, AB, T2N 4N2, Calgary, Canada.

Nicole Culos-Reed (N)

Department of Kinesiology, University of Calgary, 2500 University Dr. NW, T2N 1N4, Calgary, AB, Canada.

Linda E Carlson (LE)

Department of Oncology, University of Calgary, 2202 2nd St. SW, T2S 3C1, Calgary, AB, Canada.

Janine Giese-Davis (J)

Department of Oncology, University of Calgary, 2202 2nd St. SW, T2S 3C1, Calgary, AB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH